Ro
Total Raised
$1.027BInvestors Count
31Deal Terms
5Investments
1Funding, Valuation & Revenue
8 Fundings
Ro has raised $1.027B over 8 rounds.
Ro's latest funding round was a Series D - II for $150M on February 16, 2022.
Ro's valuation in March 2021 was $5,000M.
Ro's latest post-money valuation is from February 2022.
Sign up for a free demo to see Ro's valuations in February 2022, July 2020, April 2019, September 2018 and more.
Ro's 2020 revenue was $250M. Ro's most recent revenue is from 2020.
Sign up for a free demo to see revenue data from 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/16/2022 | Series D - II | $150M | 9 | |||
3/22/2021 | Series D | ▲$5,000M | ||||
7/27/2020 | Series C | $250M (6x) FY 2020 | ||||
4/16/2019 | Series B | |||||
9/18/2018 | Series A |
Date | 2/16/2022 | 3/22/2021 | 7/27/2020 | 4/16/2019 | 9/18/2018 |
|---|---|---|---|---|---|
Round | Series D - II | Series D | Series C | Series B | Series A |
Amount | $150M | ||||
Investors | |||||
Valuation | ▲$5,000M | ||||
Revenue | $250M (6x) FY 2020 | ||||
Sources | 9 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Ro Deal Terms
5 Deal Terms
Ro's deal structure is available for 5 funding rounds, including their Series D - II from February 16, 2022.
Round | Series D - II | Series D | Series C | Series B | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series D - II | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Ro Investors
31 Investors
Ro has 31 investors. General Catalyst invested in Ro's Series D - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/18/2017 | 2/16/2022 | 5 Seed VC, Series A (2018), Series C (2020), Series D (2021), Series D - II (2022) | Venture Capital | California | ||
8/18/2017 | 2/16/2022 | 4 Seed VC, Series A (2018), Series C (2020), Series D - II (2022) | Venture Capital | California | ||
9/18/2018 | 2/16/2022 | 4 Series A, Series C (2020), Series D (2021), Series D - II (2022) | Venture Capital | New York | ||
Venture Capital | New York | |||||
Venture Capital | New York |
First funding | 8/18/2017 | 8/18/2017 | 9/18/2018 | ||
|---|---|---|---|---|---|
Last Funding | 2/16/2022 | 2/16/2022 | 2/16/2022 | ||
Investor | |||||
Rounds | 5 Seed VC, Series A (2018), Series C (2020), Series D (2021), Series D - II (2022) | 4 Seed VC, Series A (2018), Series C (2020), Series D - II (2022) | 4 Series A, Series C (2020), Series D (2021), Series D - II (2022) | ||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Venture Capital | Venture Capital |
Location | California | California | New York | New York | New York |
Ro Acquisitions
4 Acquisitions
Ro acquired 4 companies. Their latest acquisition was Dadi on March 01, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/1/2022 | Seed / Angel | $6.8M | Acquired | 2 | ||
6/30/2021 | Other | |||||
5/19/2021 | Series A | |||||
12/8/2020 | Other Venture Capital |
Date | 3/1/2022 | 6/30/2021 | 5/19/2021 | 12/8/2020 |
|---|---|---|---|---|
Investment Stage | Seed / Angel | Other | Series A | Other Venture Capital |
Companies | ||||
Valuation | ||||
Total Funding | $6.8M | |||
Note | Acquired | |||
Sources | 2 |
Ro Investments
1 Investments
Ro has made 1 investments. Their latest investment was in Pawp as part of their Series A on April 20, 2021.
Ro Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/20/2021 | Series A | Pawp | $13.28M | Yes | Digitalis Ventures, Eight Sleep, Good Friends, Lux Capital, TRAC, and Zocdoc | 8 |
Date | 4/20/2021 |
|---|---|
Round | Series A |
Company | Pawp |
Amount | $13.28M |
New? | Yes |
Co-Investors | Digitalis Ventures, Eight Sleep, Good Friends, Lux Capital, TRAC, and Zocdoc |
Sources | 8 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Ro to Competitors
Maven serves as a virtual clinic specializing in women's and family health within the healthcare sector. The company offers continuous, holistic care services, including fertility and family building, maternity, parenting, pediatrics, and menopause management. Maven primarily serves employers and health plans, aiming to improve health outcomes and reduce healthcare costs. It was founded in 2014 and is based in New York, New York.
Thirty Madison focuses on providing virtual-first specialized healthcare services. The company offers accessible and effective treatments for people with ongoing conditions, emphasizing a lifetime of care without the need for in-person visits. It was founded in 2017 and is based in New York, New York.
DoctorBox is a digital health platform operating in the healthcare industry. The company offers an application that centralizes all important health data, providing various digital services for diagnostics, pharmaceuticals, and therapy. It primarily serves individuals seeking to manage their daily health. It was founded in 2016 and is based in Berlin, Germany.
HealthTap is a digital health company. It offers a mobile application that connect doctors with patients, giving patients access to medical experts and health advice anytime and anywhere. It was founded in 2010 and is based in Sunnyvale, California.
98point6 Technologies specializes in digital health solutions, focusing on telehealth and healthcare technology. The company offers a virtual care platform that provides asynchronous and real-time telehealth services, designed to streamline administrative tasks for clinicians and enhance patient-provider interactions. Their platform serves the healthcare industry by increasing provider efficiency and patient satisfaction through technology that supports various care modalities. 98point6 Technologies was formerly known as 98point6. It was founded in 2015 and is based in Seattle, Washington. 98point6 Technologies operates as a subsidiary of Transcarent.
Rezilient provides healthcare services. It combines telehealth services with in-person care capabilities. The company offers primary and urgent care services, accessible through both virtual and physical examinations, including labs and imaging. It provides individuals and families with convenient healthcare solutions. Rezilient was formerly known as DynamicSurgical. It was founded in 2016 and is based in Saint Louis, Missouri.
Loading...